Clinical trial
Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by…
NCT00111982 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00111982 |
|---|---|
| Title | Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin |
| Official title | Multi-Center, Open-Label Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin (Protocol 20020168) |
| Lead sponsor | Amgen, Industry |
| Collaborators | Medtronic Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Biological |
| Interventions | Liatermin |
| Enrollment | 34 |
| Start date | Dec 1, 2003 |
| Primary completion | Nov 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | May 30, 2005 |
| Last update posted | Feb 26, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: